Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...

Consumers filed over 200 complaints with some telemedicine companies for misleading customers about costs of weight loss using GLP-1 drugs.

Medicare had banned coverage of weight-loss drugs for 23 years, and what happens next isn't as simple as the headlines ...

Weight Watchers says its GLP-1 Success Program plus meds delivers significantly more weight loss than meds alone, but evidence on keeping weight off ...

March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap ...

Revolutionizing Medical Weight Loss with GLP-1 Therapy Bellingham, United States - February 25, 2026 / Mt. Baker ...

Alternatives to Ozempic for Weight Loss This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an ...

Early weight loss ≥ 2% or ≥ 3% by 4 weeks in structured weight-loss programs is significantly associated with achieving ≥ 5% or ≥ 10% total weight loss, respectively, by 16 weeks in adults with class ...

A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management programs that offer beneficial ...

A 2026 informational consumer research report examining the TMates telehealth weight-loss platform, compounded GLP-1 ...

People taking new prescription weight loss medications may be missing key nutrients they need, according to a new study.

A coalition of Hispanic health and public policy organizations is pushing for New Mexico’s Medicaid program to broaden its coverage of weight loss drugs as treatment for obesity. The policy change, ...